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ABSTRACT 
Rising concerns over multidrug resistant bacteria have necessitated an expansion to the current 
antimicrobial arsenal and forced the development of novel delivery strategies that enhance the 
efficacy of existing treatments. Antimicrobial peptides (AMPs) are a promising antibiotic 
alternative that physically disrupts the membrane of bacteria resulting in rapid bactericidal 
activity, however clinical translation of AMPs has been hindered by their susceptibility to 
protease degradation. Through the co-loading of liposomes encapsulating a model AMP, 
IRIKIRIK-CONH2 (IK8), and gold nanorods (AuNRs) into a poly(ethylene) glycol (PEG) 
hydrogel we have demonstrated the ability to protect encapsulated materials from proteolysis and 
provide the first instance of triggered release of AMPs. Laser irradiation at 860 nm, at 2.1 W cm-
2
2, for 10 mins led to the photothermal triggered release of IK8, resulting in bactericidal activity 
against Gram-negative Pseudonomas aeruginosa and Gram-positive Staphylococcus aureus. 
Furthermore, by increasing the laser intensity to 2.4 W cm-2 we have shown the thermal 
enhancement of AMP activity. The photothermal triggered release, and enhancement of AMP 
efficacy, was demonstrated to treat two rounds of fresh S. aureus, indicating the therapeutic gel 
has the potential for multiple rounds of treatment. Taken together, this novel therapeutic 
hydrogel system demonstrates stimuli-responsive release of AMPs with photothermal enhanced 
antimicrobial efficacy in order to treat pathogenic bacteria. 
 
1. Introduction 
Societal misuse and overconsumption of antibiotics has led to the emergence of multidrug-
resistant bacteria that are set to pose serious global medical, social and economic issues.
1
 Such is 
the threat that bacteria have evolved resistance to “last resort” antibiotics such as carbapenem, 
leaving critically few options for treatment.
2-3
 Naturally derived and synthetic antimicrobial 
peptides (AMPs) have been identified as a promising antibiotic alternative. AMPs act through the 
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physical disruption of the bacterial membrane, promoting cytoplasmic leakage, and resulting in 
rapid bacteria death. Further, the high metabolic cost associated with membrane repair reduces 
the risk of the emergence of drug resistance.
4-6
 However, the clinical translation of AMPs has 
suffered from the peptide instability and susceptibility to protease degradation in vivo.
7-8
 As such, 
the development of protective delivery systems is seen as a key strategy for increasing the 
chances of AMP implementation.
9-11
 However, such systems have primarily focused on the 
sustained release of AMPs, neglecting stimuli-responsive alternatives.
12-15
 Recently, systems 
utilizing the triggered delivery of antibiotics have drawn widespread attention due to their 
capacity for spatially and temporally controlled delivery of lethal antibiotic dosages.
16-19
 The 
ability to promote site-specific delivery in response to environmental cues also minimizes 
systemic loss into peripheral tissues ensuring that local microflora are not subjected to sub-lethal 
doses that may induce resistance.
4
 With the increased treatment efficacy and reduced risk of 
resistance development, we believe that the implementation of triggered delivery of AMPs could 
provide the next step toward clinical translation. 
In recent years, hydrogels have become increasingly studied as drug delivery vehicles due to the 
diversity of gel characteristics (e.g. crosslinking density, mesh size, charge, polymer density) that 
can be controlled to tailor the retention rate of impregnated materials.
20-21
 Furthermore, the 
doping of hydrogels with stimuli-responsive materials has become increasingly popular due to 
the potential for increasing the accuracy of the location and rate of drug release.
22-24
 
Traditionally, the fabrication of stimuli-responsive materials has utilized the chemical 
modification of existing biomaterials, however synthesis of these materials can be complex and 
difficult to scale-up, leading to increased cost of production and premature leakage of cargo with 
decreased functionality. 
25-26
 Such issues can in principle be circumvented by the incorporation 
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of optically active nanoparticles that, under near-infrared irradiation (NIR), exhibit photothermal 
heating that can be used to trigger drug release,
27-30
 as well as provide thermally induced 
antimicrobial effects.
31-34
 The combination of these treatments has been demonstrated to 
produce synergistic antimicrobial effects. Meeker et al. (2016) developed a daptomycin 
encapsulating gold nanocage with conjugated staphylococcal targeting proteins, 
that provided triggered antibiotic and photothermal co-therapy that demonstrated complete 
bacteria killing of both planktonic suspensions and biofilm models of S. aureus.
35
 Treatments 
utilizing the same system without laser irradiation or in the absence of the daptomycin, did not 
provide complete bacteria eradication. 
	
Liposomes are the most widely researched nanoscale antibiotic delivery system,
36-37
 
primarily due to their ability to increase the biocompatibility, bioavailability and safety 
profiles of encapsulated antimicrobial materials.
38
 Conventional liposomes predominantly 
consist of phospholipids, providing an inherent temperature dependent gel-liquid phase transition 
that increases the membrane permeability. As such liposomal photothermal delivery has been 
widely demonstrated using dye molecules and anti-cancer chemotherapeutics,
28, 39-41
 however 
equivalent systems to treat infections are lacking. Zhao et al. (2018), developed a liposome 
encapsulating tobramycin that was fabricated using 1,2-distearoyl-sn-glycero-3-phosphocholine 
(DSPC) betainylate cholesterol and the NIR therapeutic cyanine dye, cypate.
42
 Irradiation of 
these liposomes with 808 nm (2 W cm
-2
) light led to the triggered release of the antibiotic and 
photothermal bacterial killing that induced a 7- to 8-fold decrease in bacteria viability of a P. 
aeruginosa biofilm compared to free tobramycin. Similar effects may therefore also be achieved 
utilizing conventional phospholipid liposomes using separate plasmonically active nanoparticles, 
5
thus increasing the variety of liposome compositions available for the photothermal delivery of 
antimicrobials. 
 
Here, we describe a hydrogel/liposome system for the photothermal triggered release of 
antimicrobial agents (Figure 1), in which a poly(ethylene glycol) (PEG) based gel containing 
AMP-loaded liposomes and lipid coated NRs is used for the controlled treatment of bacteria. We 
have previously shown that the β-sheet forming AMP, IK8, possess potent broad-spectrum 
antimicrobial activity against various antibiotic-susceptible and antibiotic-resistant 
microorganisms.
43
 However, IK8 was found to be rapidly degraded by proteases such as trypsin 
and proteinase K, leading to a significant loss in antimicrobial activity.
44
 Here we demonstrate 
that liposomal encapsulation of IK8 protects it from proteolytic degradation. We then added both 
the IK8 liposomes and the Au nanorods (AuNRs) to the hydrogel and demonstrated the 
photothermal release of IK8 through laser irradiation at 860 nm (the peak wavelength of the  
AuNR longitudinal plasmon band). This proved effective for the treatment of both Gram positive 
and Gram-negative bacteria. Further, by increasing the laser intensity to 2.4 W cm
-2
 (60°C) we 
found photothermal enhancement of the antimicrobial properties of IK8. Finally, we have shown 





Figure 1. A schematic representation of the PEG-based hydrogel containing gold nanorods and 
antimicrobial peptide (IK8) loaded liposomes, demonstrating the mechanism for NIR light-
triggered release of AMPs.  
 
2. Materials and Methods 
2.1 Materials 
Phospholipids DSPC and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethylene glycol)-2000] (DSPE-mPEG2k) were purchased from Lipoid GmbH 
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(Ludwigshafen, Germany). Cholesterol, phosphate buffered saline (PBS) and dimethyl sulfoxide 
(DMSO, analytical grade) was purchased from Merck (Darmstadt, Germany). Mueller Hinton 
broth II (MHB II), Mueller Hinton agar II, the cell proliferation reagent WST-1, fibroblast 
growth media and adult human dermal fibroblasts (HDF, Cell Applications Inc. 106-104 05N) 
were purchased from Merck & Co. (New Jersey, USA). The AMP IRIKIRIK-CONH2 (IK8, > 
95% purity) was purchased from GL Biochem Ltd (Shanghai, China). Four-arm poly(ethylene 
glycol) maleimide (4APM, Mw 20kDa) and poly(ethylene glycol) dithiol (PEGSH, Mw 3.4 kDa) 
were purchased from Jenkem Technologies USA (Plano, USA). The pathogenic bacteria S. 
aureus (NCTC 12981) and P. aeruginosa (NCTC 12903) were obtained from Public Health 
England Culture Collections. 
 
2.2 Preparation of liposomes and determination of IK8 encapsulation efficiency  
Liposomes were prepared according to the thin film hydration method. Briefly, 
DSPC/cholesterol/DSPE-mPEG2k (65/30/5 mol%) dissolved in chloroform were mixed in a 
round bottom flask and dried under nitrogen for 1 h. The lipid film was rehydrated in a 1 ml 
solution of IK8 in PBS (pH = 7.4). The flask was then placed into a water bath preheated to 65°C 
and gently mixed for 1 h. The resulting multilamellar liposome suspension was then subjected to 
heated extrusion (65°C) through a 0.4 µm polycarbonate membrane (Whatman, Merck, 
Darmstadt, Germany) to homogenize the sample. The liposomes were then added to a 15 kDa 
molecular weight cutoff cellulose dialysis membrane (Biotech) and placed in a 2 liter bath of 
Milli-Q water which was stirred vigorously for 48 h. The Milli-Q water was replaced after 2, 4, 6 
and 24 h. 10 µl of the liposomes were extracted and 10 % v/v of DMSO was added to induce 
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peptide leakage before the sample was diluted to 300 µl. The solution was then run through an 
Agilent 1290 series high-performance liquid chromatography (HPLC) system with a 4.6 x 250 
mm Insertil ODS-SP column, through which the sample was flowed with an acetonitrile gradient 
(acetonitrile/water ratio at 0.01 mins 13:87, at 10 mins 100/0) at a rate of 2 µl min
-1
. A peak was 
observed at 220 nm after 2.56 mins corresponding to the IK8. The concentration of IK8 
encapsulated was determined by integrating the area beneath the peak and comparing this to a 
predetermined concentration curve (Figure S1). 
2.3 Liposome stability testing 
2.3.1 Thermal stability  
The thermal release of the liposomes was investigated through the release of the self-quenching 
dye calcein. Liposomes were fabricated through the hydration of lipid films 
(DSPC/cholesterol/DSPE-mPEG2k, 65/30/5 mol% respectively) using a solution of 0.1 M 
calcein dissolved in PBS. The resulting liposomes were homogenized using heated-extrusion 
before unencapsulated dye was removed by passing the liposome suspension through a 
Sephadex® G-50 gel chromatography column. The first 0.5 ml of sample to pass through the 
column was collected. The sample was then diluted 2000 times before 200 µl was added to a 96-
well plate, for measurement of the sample fluorescence (Exc/Em 496/515 nm). Thermocouples 
were then added to the wells and the plate was placed in an incubator preheated to 55°C. Once 
the temperature of the solution had been maintained at 55°C for 5 min the fluorescence was again 
measured. 1% Triton-X100 was added to the control wells to find the maximum fluorescence, 
and data normalization. 
2.3.2 Liposome leakage 
9
To assess the liposome leakage, 100 µl of calcein loaded liposomes diluted 1000 times was added 
to a 96-well plate along with 100 µl of MHB II, or MHB II S. aureus suspension (initial 
concentration 1 x 10
6
 colony forming units (CFU) ml
-1
) and incubated at 37°C. The sample 
fluorescence was measured immediately after preparation and once daily to identify passive 
leakage of calcein. 1% Triton-X100 was added to the control wells at day 0 and to all wells at the 
end of the test to identify to determine maximum fluorescence.  
2.3.3 Colloidal stability of IK8 Liposomes 
Size and polydispersity measurements were performed in triplicate using dynamic light 
scattering (DLS, Zetasizer Nano ZS) at 25°C. IK8-liposomes diluted 100 times in PBS were 
sized using a 4mW, 633nm laser with a measurement angle of 173°. In between measurements 
the liposomes were stored at 4°C. 
2.4 Liposomal protection of encapsulated AMP from protease degradation 
The efficacy of liposomal encapsulation in protecting the peptide against potential proteolytic 
degradation was tested by adding 10 µl of the proteolytic enzyme trypsin (50 µg ml
-1
) to 1 ml of 
0.1 mg ml
-1
 free IK8 and IK8-encapsulated liposomes containing the equivalent quantity of 
peptide. After an hour 150 µl of each sample was removed and the trypsin was inactivated 
through the addition of 10 µl of 40% w/w trichloroacetic acid.
45
 This process was repeated each 
hour for 5 h. The concentration of IK8 remaining in the samples was quantified using HPLC, 
liposomally encapsulated IK8 was released by adding 5% v/v DMSO before being added to the 
HPLC. 
2.5 Lipid-coating of AuNRs 
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 Binary surfactant centrimonium bromide (CTAB) and sodium oleate (NaOL) stabilized AuNRs 
were synthesized as described by Roach et al. (2018), these were then lipid coated to increase 
colloidal stability. The lipid replacement of the CTAB-NaOL bilayer was performed by initially 
forming a 10 ml suspension of liposomes via tip sonicating DSPC/DSPE-PEG2000 (95/5 mol%, 
10 mg ml
-1
) for 2 h before addition to a 10 ml AuNR solution containing 60 µg ml
-1 
of Au. The 
liposome-NR suspension was then sonicated for 24 h before pelleting using centrifugation (9,000 
x g for 30 minutes), removal of the supernatant and re-dispersal in a fresh liposome solution. 
This process was repeated three times, with the AuNR pellet dispersed into deionized water 
following the final centrifugation. The dimensions of the AuNRs were determined through 
transmission electron microscopy (TEM) imaging using a Tecnai G2 Spirit TWIN/BioTWIN 
with an acceleration voltage of 120 kV. Characterization of the AuNR absorption was measured 
using a PerkinElmer Lambda 35 spectrophotometer and the Au density was determined using 
atomic absorption spectroscopy Varian 240 fs (Figure S2d). 
2.6 Fabrication of a hydrogel containing IK8-loaded liposomes and AuNRs 
Briefly, 4APM was dissolved in 20 µl of 10mM sodium citrate buffer (pH = 6), before addition 
of lipid coated AuNRs (48 µg ml
-1
 of gold) and liposomes encapsulating 32 µg ml
-1
 of peptide, 
the suspension was topped up to 40 µl using the citrate buffer. The PEGSH was dissolved into 10 
µl of 10 mM citrate buffer and added to a well in a 96-well plate. The 4APM solution, containing 
the AuNRs and IK8-liposomes, was rapidly added to the PEGSH solution and vortexed to ensure 
thorough mixing.  
2.7 Liposome and AuNR retention within the gel 
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The retention of liposomes and AuNRs within the hydrogel was determined by incubating the 
gels with buffer and measuring the leakage of the particles daily. 50 µl PEG gels containing both 
liposomes and AuNRs were fabricated into opaque 96-well plates and 150 µl of citrate buffer was 
added to the gels after gelation. To quantify the amount of AuNRs lost from the gel the 
supernatant absorbance at 860 nm, the longitudinal absorbance wavelength of the AuNRs, was 
measured. The liposome retention was assessed by including the dye Texas Red within the 
liposome bilayer, thus providing them with a measurable fluorescence (EX/EM, 561 nm/594 
nm). The Texas Red was included by the addition of 0.5 wt% Texas Red to the lipid mixture, 
prior to the formation of the thin lipid film, the rest of the fabrication protocol was unchanged. 
The absorbance and fluorescence of the citrate buffer was measured before addition to the gels, 
and the absorbance and fluorescent values were obtained for the gels on day 0. After 24 hours the 
supernatant was added to a clean well and the absorbance and fluorescence were both measured, 
after which the solutions were added back to the gels. The liposome and AuNR release was 
determined using the equation 
𝑅𝑒𝑙𝑒𝑎𝑠𝑒 % =  100 ×
𝑋!"#$%& −  𝑋!"##$%
𝑋!"#$#%& −  𝑋!"##$%
 
where X is the fluorescence when of the liposomes or the absorbance of the AuNRs (860 nm). 
2.8 Rheometry 
The mechanical properties of the IK8-liposome and AuNR loaded gels was assessed using an 
Anton Paar modular compact rheometer 302. The storage and loss moduli (G’ and G’’ 
respectively) of the gels was obtained through applying a constant strain of 1% to the gel and by 
applying a 1% strain at frequencies of 0.1-100 Hz. A 500 µl gel was fabricated on the bottom 
12
plate of the rheometer that was preheated to 37°C. Immediately after gelation the 25 mm 
diameter top plate was lowered to 1 mm above the bottom plate before initiating the 
measurement. Silicon oil was applied to the periphery of the rheometer plates to restrict 
evaporation from the hydrogel.  
2.9 Hydrogel swelling ratios 
The swelling ratio is the fractional increase in the weight of the hydrogel due to the absorption of 
water. PEG gels of 2.5, 5 and 10 wt% were fabricated into the eppendorfs, before freeze-drying. 
The gels were then weighed before 1 ml of Milli-Q was added. After 10, 30, 60, 120, 180 and 
240 mins the excess Milli-Q was removed and the gel was weighed again. The swelling ratio was 
then calculated using: 




Where W1 is the weight of the swollen gel and W2 is the initial weight of the gel before 
hydration. 
 
2.10 Cytotoxicity testing 
To determine the cytotoxicity of the hydrogel containing IK8-loaded liposomes and AuNRs, 100 
µl of fibroblast growth media containing 5 × 10
3
 human dermal fibroblast cells was added to 
wells of a 96-well plate before incubation at 37°C for 24 h. The fibroblast growth media was 
replaced with the 90 µl of fresh media and a 10 µl 5 wt% PEG hydrogel containing liposomes 
encapsulating 32 µg ml
-1
 of IK8 and 48 µg ml
-1
 of AuNRs, fabricated as previously described 
(Section 2.6), and incubated for a further 24 h The media was then replaced with fresh media 
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containing 10% v/v of the cell viability reagent WST-1, and incubated for a further 2 h. An equal 
volume of the media containing 10% v/v WST-1 was added to wells containing no cells to 
account for the background absorbance by the WST-1 reagent. The media was transferred to 
wells that did not contain cells and the absorbance was measured at 440 and 660 nm. The relative 
viability was calculated using the equation given in Figure 2. 
 
Figure 2. The equation to determine the relative viability of cells treated with a WST-1 assay. 
2.11 Triggered release of IK8 and photothermal treatment of pathogenic bacteria 
Three distinct gels were fabricated in order to test different properties. One gel contained only 
AuNRs to test the effects of photothermal heating alone upon the bacterial suspensions. The 
second gel contained AuNRs and the minimum inhibitory concentration (MIC) of free IK8, to 
demonstrate the antimicrobial effects of the AMP when delivered alongside the photothermal 
heating. The third gel contained AuNRs and IK8-loaded liposomes, to demonstrate the triggered 
delivery of the AMP. All gels were fabricated into wells of a 96-well plate to a total of 50 µl. The 





. After one h of incubation wells were irradiated with 860 nm laser, at intensities 
between 1.8 and 2.8 W cm
-2
, for 10 min. The treated bacteria suspension was subjected to serial 
dilution before being spread onto agar plates for determination of colony counts relative to the 
untreated control bacteria incubated in MHB II. 
2.12 Repeated treatment of pathogenic bacteria 
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Hydrogels were fabricated in 96 well plates as described previously, however liposomes 
containing 2.5 times the MIC of IK8 against S. aureus were added to the 4APM solution prior to 





). The bacteria were left to incubate for 1 h before irradiating at 0, 2.1 or 2.4 W 
cm
-2
 for 5 mins, before further incubation overnight. The following day the bacteria suspension 
was removed and colony counting assays were performed to quantify the number of CFUs. The 





) before irradiation for 10 min using the same laser intensities in both treatment events. 
The samples were then incubated for 18 h before being plated onto agar plates for determination 
of colony counts as described in section 2.8.  
2.13 Statistical analysis 
All statistical analysis was performed using two-tailed student’s t-testing. Results where 
considered as statistically significant when P < 0.05, all significant results are denoted with 
asterisks with the probability range denoted in the corresponding figure caption. 
 
3. Results and discussion 
3.1 Liposomal formulation and IK8 release 
To determine the efficacy of the liposomal AMP reservoirs, the different key aspects of thermal, 
colloidal and enzymatic stability were assessed. Firstly, the passive leakage and thermal stability 
of liposomes with varying cholesterol content were investigated. Liposomes consisting of 
DSPC/DSPE-PEG2k containing 0 – 30 mol% cholesterol were loaded with the self-quenching 
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dye calcein and incubated in MHB II, at 37°C. Increasing the cholesterol concentration was 
found to significantly reduce the amount of passive leakage over a four-day observation. After 
the fourth day complete leakage of encapsulated calcein was observed from liposomes without 
cholesterol (Figure 3a), whereas those containing 10 and 20 mol% cholesterol exhibited leakage 
of 74 and 58% respectively, and liposomes containing 30 mol% cholesterol displayed negligible 
leakage. The reduction in permeability is due to the cholesterol molecules introducing 
conformational ordering of the lipid chains and creating a denser more rigid, barrier for the 
calcein to cross.
46-48
 Little leakage (<5%) was observed when these liposomes were incubated in 
5 mM of IK8, in PBS, or in the presence of HDF cells (Figure S3), meaning that neither the 
AMP nor the presence of mammalian cells interact adversely with the liposome bilayer. As such, 
we deemed the 30 mol% cholesterol liposomes the most appropriate due to their high retention 
of encapsulated materials. The thermal stability of the liposomes was assessed by following 
calcein release when heated above the gel-fluid phase transition temperature (Tm), 55°C for 
DSPC, for a period of 5 minutes. Increasing the cholesterol content from 20 to 30 mol% resulted 
in a decrease in calcein release from 55% to 16% (Figure 3b). However, when heating the 
liposomes containing 30 mol% cholesterol to 55°C in the presence of S. aureus, an increased 
release was observed with 55 ± 6% of the dye released, substantially more than from heating or 
the bacteria individually, 16 ± 2% and 25 ± 5% respectively. As such, 30 mol% cholesterol 
liposomes demonstrate high retention of encapsulated materials and an adequate release profile 
and were therefore taken forward for testing as AMP reservoirs. 
16
 
Figure 3. (a) Passive calcein leakage from DSPC/cholesterol/DSPE-PEG2k liposomes with 
varying cholesterol content when incubated for 4 days at 37°C in MHB II. Error bars indicate the 
standard deviation (n=6). Lines are guides to the eye. (b) Calcein release from liposomes 
containing 20-30 mol% cholesterol, upon heating to 55°C for 5 mins (diagonal striped), 
incubation with S. aureus (hashed) and heating to 55°C in the presence of the bacteria (solid 
grey). 100% calcein release was determined through the addition of 1% Triton X-100 to the 
liposome samples in each environment on day 0. Error bars indicate the standard deviation (n=6). 
Next the liposomal encapsulation efficiency of IK8 was assessed to ensure sufficient loading of 
the AMP at bactericidal concentrations. The IK8 concentration in the solution used to hydrate the 
lipid film was varied and a concentration of 5 mg ml
-1
 enabled the encapsulation of 770 ± 21 µg 
ml
-1
 of IK8 (Figure 4a), approximately 24 times the minimum inhibitory concentration (MIC) 
against S. aureus (32 µg ml
-1
, Figure S4), whilst providing low sample-to-sample variability, 
compared to film-hydration using higher IK8 concentrations. The mass of encapsulated IK8 
increased linearly with the concentration of IK8 used to hydrate the lipid film, however, the 
proportion of the initial IK8 added to the lipid film that is encapsulated decreases causing a drop 
a) b) 
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in the encapsulation efficiency from 24 ± 4% to 13 ± 2%. The resulting liposomes showed 
excellent colloidal stability with little change in size upon incubation in PBS at 4°C, over a three-
week observation period (Figure 4b). Post fabrication, the liposome diameter was 365 ± 36 nm 
with a coefficient of variation (CV) of 0.12 ± 0.05, whereas after 3 weeks the liposome diameter 
increased slightly to 385 ± 42 nm (CV = 0.17 ± 0.04). 
 
Figure 4.  (a) Liposome encapsulation efficiency (circles) and mass of encapsulated peptide 
(diamonds) upon increasing the concentration of IK8 used to hydrate the thin lipid film during 
liposome fabrication. Error bars indicate the standard deviation (n=3). (b) Diameter of liposomes 
encapsulating 0.8 mM IK8 (solid line) and coefficient of variation (diamonds) of the liposomes 
observed over a course of three weeks. Error bars indicate the standard deviation (n=3).	
The final stage of testing was to assess the efficacy of encapsulation against enzymatic 
degradation. Despite the great potential of AMPs as antibiotic alternatives, clinical translation 
has been hindered by proteolytic instability in vivo.49 By loading AMPs within delivery vehicles, 
it is possible to protect the AMP from protease degradation before reaching the infection site, 
greatly enhancing treatment efficacy.50 To test the liposomal protection of encapsulated IK8 
against degradation we incubated free and liposomal IK8 in a trypsin solution for 5 h. Our data 
a) b) 
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shows that 81 ± 6% of liposome encapsulated IK8 remained intact, over double that of the free 
IK8 in solution, 36 ± 2% (Figure 5). The lipid bilayer encapsulating the IK8 therefore provides a 
protective barrier that restricts access of proteases, thus potentially allowing treatment infection 
environments that are often rich in such proteolytic enzymes, such as an open wound.51 
 
Figure 5. Enzyme degradation of IK8 by trypsin. The IK8 remaining within a sample when 10 µl 
of 50 µg ml
-1
 of trypsin was added to 1 ml solutions containing 0.1 mg ml
-1
 of IK8 free in 
solution (solid line) or an equal quantity of IK8 encapsulated within liposomes (dashed line) 
(n=3). p-values indicate; *  ≤ 0.05, ** ≤ 0.01, *** ≤ 0.001. 
3.2 Hydrogel formation 
IK8-liposome / AuNR loaded hydrogels were prepared by mixing the nanoparticles with 4APM 
as the monomer, before initiating gelation using a PEGSH solution. This gelation occurs through 
a Michael-type reaction between the maleimide and thiol groups of the two PEG molecules, 
providing a gel with tunable gelation rates and mechanical properties.52-54 The PEG hydrogel was 
also chosen due to its high permeability by small hydrophilic molecules, meaning the gel should 






















** *** ** **
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provide minimal interference with the AMP release kinetics.
55
 By controlling the pH and the 
buffer concentration the gelation time could be varied up to two minutes. A 5 wt% gel with a 
gelation time of 20 seconds was deemed appropriate, as this produced a stiff gel and allowed for 
a reasonable mixing time. Gels greater than 5 wt% were stiff and difficult to mix, whereas the 
2.5 and 1 wt% gels were very ductile almost fluidic, as shown by the small discrepancy between 
the storage and loss moduli (Figure S5a). The 5 wt% gel also was also advantageous in terms of 
it’s swelling in an aqueous environment. The swelling ratio of the gels was found to decrease as 
the wt% increased, after 4 hours the 2.5, 5 and 10 wt% gels displayed ratios of 30.4 ± 5.6 
(absorbing 41 ± 1 mg of Milli-Q), 22.4 ± 1.8 (59 ± 2 mg of Milli-Q) and 19.0 ± 1.8 (87 ± 6 mg of 
Milli-Q) respectively, Figure S6. A swelling decrease with the gel wt% has been identified in 
similar 4 arm PEG hydrogels with comparable swelling ratios.56 The 5 wt% gel absorption 
saturated at ~59 mg of liquid, as such the gel, already containing 50 mg of citrate buffer, would 
only swell to absorb another 9 μl of any liquid added to the gel. The quantity of IK8-liposome 
solution added to the 4APM solution was determined by quantifying the IK8 concentration and 
adding the required volume such that upon photothermal stimulation the MIC of IK8 would be 
released. Alongside the liposomes, 48 µg ml
-1 
of lipid-coated AuNRs (60 x 14 nm, Figures S2a 
and S2b) were added, as this was the minimum concentration of particles required to heat the 
sample to 65°C, using a laser intensity of 2.8 W cm
-2
, at the AuNR longitudinal resonance peak 
of 860 nm (Figure S2c). Lipid-coated AuNRs were chosen as these showed a significant 
decrease in toxicity to S. aureus compared to the binary surfactant CTAB-NaOL coating used 
during the synthesis the AuNRs (Figure S5). After treatment with the AuNRs the bacteria were 
pelleted and the AuNR in suspension were discarded, at the highest concentration we inoculated 
the bacteria with (250 µg ml
-1
) the lipid-coated AuNRs did not completely inhibit bacteria 
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proliferation. The inclusion of peptide-loaded liposomes and lipid-coated AuNRs produced a 
more malleable gel (Figure S5b) but it did not alter the gelation time and under visual inspection 
the transparent gel had a slight uniform brown coloration indicating a homogenous distribution 
of the NRs. The gel also retained the majority of both liposomes and the lipid-coated AuNRs 
when observed over a 7-day observation with 9 ± 2% and 10 ± 2% released into the surrounding 
media respectively (Figure S8). The gel transparency also offers the additional benefit of being 






Figure 6. (a) Photothermal heating profiles of the AuNR loaded hydrogel under varying laser 
intensities for 10 minutes, starting from a base temperature of 35°C. (b) The photothermal 
heating profile of the NR loaded gel over repeated irradiation cycle at 2.4 W cm
-2
 laser intensity 
for 10 minutes. (c) AuNR and calcein liposomes loaded into the PEG hydrogel, irradiated for 10 
mins at 860 nm with intensities of 0 W cm
-2
 and 2.4 W cm
-2
, the Eppendorfs on the left and right 
respectively. (d) Bacterial and photothermal induced release of calcein (diagonal lines and 
hashed columns respectively) from liposomes in PEG gels of different wt% when incubated in a 
S. aureus suspension.  All gels contained 48 µg ml
-1
 of AuNRs and a laser power of 1.4 W cm
-2
 
was used to irradiate the samples to 55°C for 5 mins. Error bars indicate the standard deviation 
(n=6). 
The photothermal response of the AuNR-loaded gels was characterized in order to control the 
thermally induced liposome release of AMPs.  The fabricated hydrogels and MHB II were 
irradiated with a continuous wave laser, 860 nm, at 1.8 – 2.8 W cm
-2 
for 10 min. This gave 
control of the saturation temperature within the wells to between 50 and 65°C (±1°C) which was 
reached in 5 mins and maintained for a further 5 min (Figure 6a). The photothermal efficiency 
was maintained through repeated irradiation cycles (Figure 6b) and the gel containing calcein-
loaded liposomes exhibited a visible increase in fluorescence after laser irradiation at 2.4 W cm
-2
 
(Figure 6c). These results demonstrate the ability to achieve dose-dependent temperature 
increases with the NR-loaded hydrogels and provide reproducible levels of heating (with the 
same temperature attained) over several irradiation cycles. The reproducibility of the heating 
profiles indicates that there is no change in optical properties and therefore no reshaping or 
aggregation of the AuNRs under irradiation, at these laser intensities. Subsequently, 64 ± 6% of 
liposome encapsulated calcein was release when the liposomes were loaded into a 5 wt% gel and 
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irradiated at 2.4 W cm
-2
, heating the sample to 55°C, an increase upon the calcein released from 
liposomes free in suspension, 56 ± 2% (Figure 6d). This increase may be due to the confinement 
of the liposomes and AuNRs within the 50 µl volume of the gel, rather than when they are free in 
solution and are able to diffuse throughout the 200 µl total volume of liquid. This would increase 
the likelihood of the liposomes and thermally radiating AuNRs being in a close proximity to one 
another making the liposomes more susceptible to thermal destabilization. 
3.3 Cytotoxicity of the therapeutic gel   
Considering the cytotoxicity of any dressing used on a wound susceptible to infection is of vital 
importance. Hindering the regenerative process through increasing the toxicity to mammalian 
cells leaves the wound vulnerable to infection and increases the risks of a wound becoming 
chronic.57 As such, the cytocompatibility of the therapeutic gel was assessed using HDF cells; 
which play a critical role in the formation of granulation tissue.58 Incubation of the HDF cells 
with the AuNR and IK8-liposome loaded 5 wt% PEG gel for 24 h showed no detrimental effects 
on cell viability; with > 97% cell viability observed in the formulation used (Figure 7a). 
Furthermore, no cytotoxicity was observed upon incubation of the HDF cells with either the lipid 
coated AuNRs or free IK8 in media at concentrations four times greater than those required to 
fabricate the therapeutic hydrogel (Figure 7b). As such, each component within the therapeutic 
gel demonstrates excellent biocompatibility indicating that the gel would be suitable for 
treatment of infections in a vulnerable wound environment. The lack of cytotoxicity of IK8 at 
concentrations several times the MIC against S. aureus potentially allows for the liposomal 
loading of high concentrations of peptide to provide multiple treatment events, with no risk of 




Figure 7. a) Cytotoxicity of the 5 wt% PEG hydrogel and the therapeutic IK8 liposomes-NR 
loaded 5 wt% PEG hydrogel when incubated with HDFs for 24 h. Error bars indicate the 
standard deviation (n=6). b) The cytotoxicity of lipid coated AuNRs and IK8 in suspension, after 
24 h. Error bars indicate the standard deviation (n=6). 
3.4 Triggered release of IK8 and photothermal treatment of pathogenic bacteria 
The antimicrobial properties of the AuNR and IK8-liposome loaded gel were assessed through 
the treatment of Gram-positive S. aureus and Gram-negative P. aeruginosa. By controlling the 
applied laser irradiation intensity between 1.8 and 2.8 W cm
-2
, we were able to provide 
photothermal heating profiles between 50 °C and 65 °C and demonstrate the first instance of 
triggered release of AMPs from liposomes.  The triggered release of IK8 was observed to occur 
for an irradiation of 2.1 W cm
-2
 for 10 minutes and heating the sample to 55°C.  This produced 
6- and 9-log reductions in the number of CFU ml
-1
 when treating S. aureus and P. aeruginosa 
respectively (Figure 8), demonstrating the first instance of triggered release of AMPs to incite 
bactericidal activity. No decrease in bacteria viability was observed when treating either bacteria 
a) b) 




















B: Media + 10 µl citrate buffer
C: Media + 10 µl 5 wt% PEG gel
D: Media + 10 µl 5 wt% PEG gel loaded with IK8 liposomes + AuNRs
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with a laser intensity of 1.8 W cm
-2
, 50°C. This clearly indicates that the sample must be heated 
to the lipid gel-fluid phase transition temperature of DSPC (55°C) in order to trigger release of 
encapsulated materials.
59-61
 The thermally induced release is highest close to the phase transition 
temperature, Tm, due to the coexistence of both gel and fluid domains, producing grain 
boundaries that have an increased permeability of hydrophilic molecules.
62-63
 The liposomal 
release of the MIC of IK8 showed a similar level of bactericidal activity as the gel containing the 
MIC of free IK8 against both bacterial types, ~5.5- and ~6.7-log reductions in CFU ml
-1
 against 
S. aureus and P. aeruginosa respectively. This indicates that the liposomal encapsulation and 
subsequent triggered release did not affect the peptide’s antimicrobial efficacy. When taken 
together with the liposomal protease protection, these results indicate that this therapeutic gel 
offers a potential means of maintaining AMPs in a protease rich wound environment until 
required, with no decrease in bactericidal efficacy upon triggered release. By utilizing a 
photothermal trigger, we are also able to enhance the bactericidal activity of the therapeutic gel 
by heating the bacteria to higher temperatures. Enhanced bacterial kill was observed when 
treating both bacteria with IK8 and laser irradiation at 2.4 W cm
-2
 (60°C) for 10 min, leading to a 
7.8-log reduction in CFU ml
-1
 of S. aureus and complete bacteria killing of P. aeruginosa. This 
is similar to previous observations demonstrating thermal enhancement of antibiotics against 
planktonic S. aureus35 and P. aeruginosa42, 64. Furthermore, similar studies of the antimicrobial 
effects of photothermal heating up to ~50-60°C for 10 mins have been performed in vivo on 
cutaneous wounds and demonstrated no thermally induced damage to peripheral tissues or 
detrimental effects upon reepithelialization.65-68 Through the fabrication of gels containing 
AuNRs only, we also evaluated the antimicrobial effects of photothermal heating alone. Neither 




(heating to 60°C), at which point there was a 2.6-log decrease in S. aureus and a 4.4-log decrease 
in P. aeruginosa. Further increase in the laser intensity to 2.8 W cm
-2
 (heating to 65°C) showed 
complete antimicrobial killing of both bacterial species in all samples containing the NRs. All 
bactericidal activity was attributed to the photothermal heating, with no bacteria death observed 
under irradiation at 2.8 W cm
-2
 in the absence of AuNRs. These results show that the IK8 
liposome and AuNR loaded hydrogel has the potential for use as a broad-spectrum antimicrobial 
treatment that, through the regulation of the applied laser intensity, can not only trigger the 
release of AMPs, but amplify their antimicrobial effects. By harnessing the photothermal 
enhancement, the chances of providing non-lethal treatment are reduced and as such this 
treatment should provide a decreased likelihood of bacterial AMP resistance. 
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Figure 8. The number of viable (a) S. aureus and (b) P. aeruginosa, CFU following treatment 
with gels containing AuNRs, AuNRs and free IK8, and AuNRs with IK8-loaded liposomes, 
irradiated with an 860 nm laser, at intensities between 1.8 - 2.8 W cm
-2
 for 10 mins. Black dots 
indicate no CFU remained. Error bars indicate the standard deviation over three independent 
experiments. p-values indicate; ***  ≤ 0.001, **** ≤ 0.0001. 
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The ability to utilize the hydrogel as a drug depot to provide repeated triggered release of 
antimicrobial agents at lethal dosages and in combination with photothermal ablation of bacteria 
would provide significant advantages in wound management. To demonstrate this, gels were 
fabricated with AuNRs and an increased number of liposomes such that they contained 2.5 times 
the MIC of IK8. The gels were inoculated with the first round of S. aureus before irradiation at 
2.1 or 2.4 W cm-2 for 5 mins, resulting in release of 43 ± 8 % of encapsulated materials (Figure 
S9). The bacteria were then incubated with the gel for 18 h, before removal and quantification of 
CFU ml-1. The gel was then inoculated with a fresh S. aureus suspension and subjected to 
irradiation at 2.1 or 2.4 W cm-2 for 10 minutes, before incubation for 18 h. The second round of 
bacteria was then removed for CFU quantification. Under irradiation at 2.1 W cm-2 (heating to 
55°C), the triggered release of IK8 resulted in bactericidal activity over both treatment cycles, 
with ~7.1- and 3.8-log reductions in S. aureus after the first and second cycles respectively 
(Figure 9). The decrease in antimicrobial efficacy is attributed to the diminishing number of 
intact IK8-liposomes remaining after each release event. The photothermal enhancement of IK8 
can also be observed over both treatments, under irradiation at 2.4 W cm
-2
 (60°C). The 
photothermal heating produced further 1.1- and 2.5- log reductions in CFUs, in the first and 
second cycles respectively, compared to systems providing bacteria killing through only AMP 
delivery. Using a gel containing only AUNRs the difference in photothermal killing was 
confirmed to be due to the alterations in irradiation time, with the 5 min irradiation in treatment 
one resulting in a ~0.5-log decrease in CFU ml
-1
 and the 10 min irradiation during treatment two 
producing a ~2.6-log reduction in CFU ml
-1
. The bactericidal activity of the gel, both with and 
without the photothermal enhancement, demonstrates the potential for multiple therapeutic 
events and can be optimized for a variety of treatments. Furthermore, this indicates that the main 
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limitation in the number of treatments that can be performed is the concentration of antimicrobial 
agents encapsulated within the system.  
 
Figure 9. The log reductions in S. aureus CFUs over two treatment cycles when treated with the 
the PEG hydrogel containing 48 µg mL
-1
 of AuNRs irradiated with a laser intensity of 2.4 W cm
-
2
 (grey), and gels containing AuNRs and liposomes encapsulating 2.5 times the MIC of IK8 
irradiated at 0 W cm-2 (hashed), 2.1 W cm-2 (diagonal slashed) and 2.4 W cm-2 (horizontal lined). 
Gels were irradiated for a period of 5 mins during the first treatment event and left to incubate 
for 18 h before being replaced with fresh bacteria and irradiated for 10 mins during the second 
treatment. Error bars indicate the standard deviation (n=3). p-values indicate; *  ≤ 0.05, **** ≤ 
0.0001. 
4. Conclusion 
We have demonstrated a AuNR / AMP liposome loaded hydrogel, that can effectively treat 
pathogenic bacteria through the photothermal stimulated release of AMPs, which is, to our 
knowledge, the first instance of triggered release of AMPs in response to exogenous stimuli. 
Irradiation at 2.1 W cm
-2
 for a period of 10 min caused heating to 55°C, triggering the release of 
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IK8 resulting in ~6- and ~7-log reductions in the number of Gram-positive S. aureus and Gram-
negative P. aeruginosa CFUs respectively. Increasing the laser intensity to 2.4 W cm
-2
, heating 
to 60°C, enhanced the antimicrobial activity of the system with additional 2- and 5-log 
reductions in viable S. aureus and P. aeruginosa respectively. Through the optimization of the 
irradiation time and increasing the number of AMP-loaded liposomes, such that the final 
concentration of IK8 was 2.5 times the MIC against S. aureus, the gel was shown to release 
bactericidal dosages of AMP to treat two sequential bacterial suspensions, resulting in 7- and 4-
log reductions in CFU ml
-1
 from the first and second treatment cycles respectively. Furthermore, 
irradiation at 2.4 W cm
-2 
demonstrated enhanced antimicrobial activity over both treatment 
cycles. This demonstrates the capability to perform multiple treatment events using an individual 
gel, offering a reduced cost per treatment. The liposomal encapsulation of AMPs provides a 
protective effect against protease degradation, with over 80% of liposome-encapsulated peptide 
remaining active after a 5-hour incubation with the proteolytic enzyme trypsin. Whilst AMP 
protection by lipid micelle has previously been documented, this demonstration of the liposomal 
AMP protection allows the delivery of higher drug doses and opens the door for a wider variety 
of AMP delivery systems. This gel system would in principle therefore allow the in vivo delivery 
of antimicrobial agents that otherwise are susceptible to degradation. Similar studies have also 
demonstrated the photothermal destruction of biofilms using nanorod loaded hydrogels,69 and 
given the innate antibiofilm properties of IK843 we believe that the photothermal enhancement of 
these properties will be able to continue into the treatment of mature biofilms, which are more 
representative of infections than treating planktonic bacteria. Taken together, these results 
indicate that the facile integration of AMP-loaded liposomes and AuNRs into a PEG hydrogel 
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network offers protection of encapsulated materials and tunable release profiles showing 
potential for the treatment of infection.  
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AMP: Antimicrobial peptide 
IK8: IRIKIRIK-CONH2 
AuNR: Gold nanorod 
PEG: Poly(ethylene) glycol 




PBS: Phosphate buffered saline 
DMSO: Dimethyl sulfoxide 
MHB II: Mueller-Hinton broth II 
WST-1: Water soluble tetrazolium salt-1 
HDF: Human dermal fibroblast 
4APM: 4-arm poly(ethylene)glycol-maleimide 
PEGSH: Poly(ethylene)glycol dithiol 
HPLC: High performance liquid chromatography 
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CFU: Colony forming unit 
DLS: Dynamic light scattering 
TEM: Transmission electron microscopy 
MIC: Minimum inhibitory concentration 
Tm: Phase transition temperature 
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